Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Price:
162.8
CNY
-0.12%
Market Closed
Market Cap:
¥98.2B
Relative Value
The Relative Value of one
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 162.8 CNY,
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Competitors
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
98.2B CNY | 10 | 40.6 | 39.5 | 39.5 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
986.9B USD | 15.1 | 47.8 | 32.2 | 34.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
596.5B USD | 6.3 | 22.3 | 15.4 | 19 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
293B CHF | 4.8 | 31.2 | 13.1 | 15.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
249.7B CHF | 5.7 | 23 | 14.2 | 18.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
240.5B GBP | 5.5 | 31.7 | 17.5 | 24.7 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
305.9B USD | 4.7 | 16.8 | 10.4 | 12.6 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.4 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.9B USD | 2.5 | 20.2 | 7.7 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.6B USD | 2.6 | 17.8 | 7.4 | 9.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
